KUALA LUMPUR: Metro Healthcare Bhd, which transferred its listing from the LEAP Market to the ACE Market today, edged higher on its trading debut.
The fertility and maternity specialist added 1.5 sen, or 6% to 26.5 sen against its initial public offering (IPO) price of 25 sen. It is currently the most active counter on Bursa Malaysia with 96.94 million shares traded at 9.46 am.
Metro Healthcare raised RM39mil from its IPO and will utilise the bulk of its proceeds for the acquisition. It is also looking to expand its network to seven in vitro fertilisation centres by 2025, with new locations in Ipoh and Kelantan.
For the first half of the financial year ending June 30, 2024, Metro Healthcare's net profit rose 24.65% to RM3.54 mil, up from RM2.84 mil a year ago, while revenue grew 12.81% to RM24.5 mil, compared to RM21.7 mil.